FDA Wouldn’t Defend Its Own Mifepristone Rule in Court

Imani Gandy breaks down what actually happened at this week's oral argument in Louisiana v. FDA, why one judge called Louisiana's own strategy "self-defeating," and why the FDA's silence in that courtroom should worry you more than anything Louisiana said there.